Mankind Pharma Limited (NSE:MANKIND)
2,038.80
+14.80 (0.73%)
At close: Mar 27, 2026
-15.18% (1Y)
| Market Cap | 841.67B -10.3% |
| Revenue (ttm) | 139.14B +19.5% |
| Net Income | 17.79B -12.8% |
| EPS | 43.10 -15.2% |
| Shares Out | 412.83M |
| PE Ratio | 47.19 |
| Forward PE | 36.24 |
| Dividend | 2.00 (0.10%) |
| Ex-Dividend Date | n/a |
| Volume | 542,413 |
| Average Volume | 737,117 |
| Open | 2,038.00 |
| Previous Close | 2,024.00 |
| Day's Range | 2,020.30 - 2,052.60 |
| 52-Week Range | 1,909.70 - 2,716.50 |
| Beta | 0.18 |
| RSI | 44.71 |
| Earnings Date | May 22, 2026 |